Position in EXEL
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$542,471,563
+$100,771,515 QoQ
Shares Held
9,970,071
-3.2% QoQ
Ownership
4.02%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#7
of 756 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 14%
Shared 0%
None 85%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. EXEL ranks #11 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,871,459 | $5,896,909,829 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,834,688 | $3,014,621,355 | |
| 3 | INCY |
Incyte Corp
|
9,722,336 | $1,102,124,008 | |
| 4 | MRNA |
Moderna, Inc.
|
15,726,193 | $1,101,305,295 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,555,689 | $1,070,369,059 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
4,897,051 | $917,119,711 | |
| 7 | RPRX |
Royalty Pharma plc
|
12,338,229 | $691,804,500 | |
| 8 | INSM |
INSMED Inc
|
6,052,174 | $645,282,791 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $542,471,563 | 9,970,071 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $441,700,048 | 10,298,439 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $459,835,519 | 10,491,342 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $459,041,859 | 11,114,815 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $501,835,856 | 11,384,661 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $435,272,475 | 11,789,612 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $380,017,701 | 11,411,943 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $296,963,184 | 11,443,668 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $283,159,210 | 12,601,656 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $310,421,788 | 13,081,407 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $312,657,303 | 13,032,818 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $270,519,256 | 12,380,744 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $246,352,494 | 12,891,287 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $251,518,564 | 12,958,195 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $220,966,526 | 13,775,968 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $204,152,032 | 13,019,900 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $262,256,631 | 12,596,380 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $257,921,260 | 11,377,206 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $206,548,315 | 11,299,142 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $224,221,832 | 10,606,520 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $178,038,205 | 9,771,581 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $208,742,059 | 9,240,463 | Shares | Defined | 2021-07-09 | |
| 2020-12-31 | $205,258,278 | 10,227,119 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $223,829,627 | 9,154,586 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $229,616,912 | 9,672,153 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $195,532,669 | 11,354,975 | Shares | Defined | 2020-06-19 | |
| No filing history on record for this holder in this stock. | ||||||